Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAZO TAB 1MG | 1MG | TABLET | Resolved | 2023-01-20 | 2025-03-12 | 181967 |
| APO-PRAZO TAB 1MG | 1MG | TABLET | Resolved | 2020-04-13 | 2020-06-22 | 111946 |
| APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2017-11-28 | 2018-01-29 | 31019 |
| APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2020-09-02 | 2020-10-16 | 123574 |
| APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2023-04-06 | 2025-03-12 | 188943 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2023-03-02 | 2025-03-12 | 185924 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2020-04-15 | 2020-06-22 | 112192 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2020-08-12 | 2020-10-19 | 122074 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2022-12-09 | 2023-01-20 | 177594 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2018-03-13 | 2018-06-12 | 42700 |
| APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2018-11-21 | 2019-03-26 | 67409 |
| APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2017-05-24 | 2017-09-22 | 11041 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-06-13 | 2018-01-19 | 12695 |
| APO-PREGABALIN | 225MG | CAPSULE | Resolved | 2017-08-08 | 2017-09-22 | 18553 |
| APO-PREGABALIN | 150MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-07-18 | 216726 |
| APO-PREGABALIN | 225MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-11-14 | 216729 |
| APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-12-05 | 216732 |
| APO-PREGABALIN | 300MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-08-22 | 216735 |
| APO-PREGABALIN | 50MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-11-14 | 216738 |
| APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-07-18 | 216741 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |